Multi-modal cancer therapy using viral hitchhiking
Cancer therapies based on immunological methods are a rapidly expanding field of cancer treatment options. However, one major problem immunebased cancer therapies face is that cancer cells manage to escape immunological control during their evolution. Methods enabling the immune system to rerecognize tumor cells are therefore an essential part of immune cancer therapies. The present invention is based on a fusion protein that substantially enhances the tumordestroying effect of T-cells against tumor cells marked with Newcastle disease virus (NDV).
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…